Summary
The effects of salbutamol 0.225 mg/kg given systemically on lung function in infants have been measured by whole-body plethysmography in 60 children with broncho-pulmonary diseases (24 after respiratory distress syndrome, 21 with wheezy bronchitis and 15 with cystic fibrosis). A therapeutic action was demonstrated in 74% of the tests, taking into account changes in end-expiratory resting level (state of inflation) and associated changes in airway resistance.
There was a significant decrease in thoracic gas volume as an estimate of pulmonary hyperinflation, which was due to improved alveolar ventilation and to a consequential decrease in end-expiratory resting level. The improvement in airway resistence, as an estimate of airway obstruction, reflects a substantial relaxation of bronchial smooth muscle increasing the diameter of the airways.
The extent to which similar results may be achieved by topical administration of nebulised beta agonists remains to be determined.
Similar content being viewed by others
References
Lenney W, Milner AD (1978) Alpha- and beta-adrenergic stimulants in bronchiolotis and wheezy bronchitis in children under 18 months of age. Arch Dis Child 53: 707–709
Phelan PD, Williams HE (1969) Sympathomimetic drugs in acute viral bronchiolitis. Pediatraics 44: 493–497
Radford M (1975) Effect of salbutamol in infants with wheezy bronchitis. Arch Dis Child 50: 535–538
Rutter N, Milner AD, Hiller EJ (1975) Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis. Arch Dis Child 50: 719–722
Stockes GM, Milner AD, Hodges IGC, Henry RL, Elphick MC (1983) Nebulised therapy in acute severe bronchiolotis in infancy. Arch Dis Child 58: 279–283
Milner AD (1980) Response to bronchodilator drugs in the first five years of life. Eur J Clin Pharmacol 32: 23–26
O'Callaghan O, Milner AD, Swarbrick A (1986) Paradoxical deterioriation in lung function after nebulised Salbutamol in wheezy infants. Lancet 2: 1424–1425
Logvinoff MM, Lemen RJ, Taussig LM, Lamont BA (1985) Bronchodilators and diuretics in children with bronchopulmonary dysplasia. Pediatr Pulmonal 1: 198–203
Soto ME, Sly PD, Uren E, Taussig LM, Landau LI (1985) Bronchodilator response during acute viral bronchiolotis in infancy. Pediatr Pulmonol 2: 85–90
Sosulski R, Abbasi S, Bhutani VK, Fox WW (1986) Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 2: 269–273
Gomez-Del Rio M, Gerhard T, Hehre D, Feller R, Bancalari E (1986) Effect of a beta-agonist nebulization on lung function in neonates with increased pulmonary resistance. Pediatr Pulmonol 2: 287–291
Helms P, Taylor BW, Milner AD, Hatch DJ (1982) Critical assessment of jacket plethysmographs for use in young children. J Appl Physiol 52: 267–273
Silverman M (1984) Bronchodilator for wheezy infants? Arch Dis Child 59: 84–87
Kraemer R, Meister B, Schaad UB, Rossi E (1983) Reversibility of lung function abnormalities in children with perennial asthma. J Pediatr 102: 347–350
DuBois AB, Bothelho SY, Bedell GN, Marshall R, Comroe JH (1965) A rapid plethysmographic method for measuring TGV: Comparison with N2 washout for measuring FRC in normal subjects. J Clin Invest 35: 322–326
Stocks J, Godfrey S (1977) Specific airway conductance in relation to postconceptional age during infancy. J Appl Physiol 43: 141–154
Polgar G, Weng TR (1979) The functional development of the respiratory system. Am Rev Disp Dis 120: 625–695
Koehler D, Schuemichen C, Matthys H (1985) Eine neue Apparatur zur individuellen dosisgenauen Applikation von Aerosolen. Klin Wochenschr 63 [Suppl V] 232–236
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kraemer, R., Birrer, P., Sennhauser, F.H. et al. Short-time response characteristics of salbutamol in infants with broncho-pulmonary diseases. Eur J Clin Pharmacol 34, 339–342 (1988). https://doi.org/10.1007/BF00542433
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542433